Novartis Digital Strategy Dampens COVID-19 Impact

Stockpiling Brings $400m Q1 Sales Boost

The Swiss major says operations have not faced significant disruptions from the coronavirus pandemic but recruitment of patients for new trials, including a high-profile trial of inclisiran, have been impacted.

Vas Narasimhan
Vas Narasimhan • Source: Novartis

The major investments that Novartis AG has made in digital technology over the past few years has helped the Swiss major manage the first phase of the coronavirus crisis, claims CEO Vas Narasimhan.

Speaking to reporters as Novartis unveiled a strong set of financials for the first quarter, Narasimhan said that in terms...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

More from Business